INJ Coin (Injective) is currently trading around $3.55–$3.65 USD (as of early February 2026), down ~2–3% in the last 24 hours and over 20% in the past week. This reflects heavy selling pressure, oversold RSI (~27–30), and broader altcoin weakness tied to crypto market pullbacks and derivatives liquidations.
For next week (mid-February 2026), short-term outlook is mixed but leans toward potential stabilization or mild recovery:
Many models and analysts forecast a range of $3.50–$3.90, with possible bounce to $3.70–$3.95 (or higher toward $4.00–$4.35 in bullish cases) if oversold conditions trigger buying, support near $3.45–$3.50 holds, and volume picks up.
Bearish risks include further dip to $3.30–$3.45 if momentum stays weak, especially with strong sell signals from moving averages and if BTC/altcoin rotation continues lower.
Some optimistic views target $4+ short-term as a step toward $5.80–$6.20 recovery by month-end, driven by Injective's strong DeFi/perps ecosystem, tokenized assets, and potential catalysts.
Overall sentiment is cautious-bearish near-term due to recent drops, extreme fear levels, and technical breakdowns, but oversold indicators and protocol fundamentals (high TPS, growing adoption) hint at rebound potential. Crypto remains volatile—monitor BTC trends, global macro, and Injective news closely.
$INJ #İNJ